Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
gZ3bnzrJ4e78A9af